Astellas Pharma Inc. (4503.T)
JPY 1458.0
(1.32%)
JPY 1458.0
(1.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1603.67 Billion | 1518.61 Billion | 1296.16 Billion | 1249.52 Billion | 1300.84 Billion | 1306.34 Billion |
| Cost of Revenue | 391.3 Billion | 288.35 Billion | 253 Billion | 246.06 Billion | 276.73 Billion | 292.05 Billion |
| Gross Profit | 1212.36 Billion | 1230.26 Billion | 1043.15 Billion | 1003.46 Billion | 1024.1 Billion | 1014.29 Billion |
| Operating Expenses | 1034.29 Billion | 1098.7 Billion | 912.19 Billion | 867.89 Billion | 778.45 Billion | 768.76 Billion |
| Selling, General and Administrative Expenses | 740.11 Billion | 630.27 Billion | 548.84 Billion | 504.31 Billion | 499.29 Billion | 490.26 Billion |
| Research and Development Expenses | 294.18 Billion | 276.12 Billion | 246.01 Billion | 224.48 Billion | 224.22 Billion | 208.68 Billion |
| Other Expenses | - | - | 117.34 Billion | 139.08 Billion | 54.93 Billion | 69.81 Billion |
| Cost and Expenses | 1425.6 Billion | 1387.06 Billion | 1165.2 Billion | 1113.95 Billion | 1055.19 Billion | 1060.81 Billion |
| Operating Income | 124.6 Billion | 133.02 Billion | 155.68 Billion | 136.05 Billion | 243.99 Billion | 243.91 Billion |
| Interest Expense | 12 Billion | 8.77 Billion | 4.94 Billion | 2.33 Billion | 3 Billion | 1.3 Billion |
| Income Tax Expense | 7.92 Billion | 33.64 Billion | 32.8 Billion | 24.73 Billion | 49.93 Billion | 26.7 Billion |
| Earnings before Tax | 24.96 Billion | 132.36 Billion | 156.88 Billion | 145.32 Billion | 245.35 Billion | 248.96 Billion |
| Net Income | 17.04 Billion | 98.71 Billion | 124.08 Billion | 120.58 Billion | 195.41 Billion | 222.26 Billion |
| Earnings Per Share Basic | 9.50 | 54.24 | 67.08 | 64.93 | 104.15 | 115.05 |
| Earnings Per Share Diluted | 9.47 | 54.09 | 67.05 | 64.90 | 104.08 | 114.94 |
| Weighted Average Shares Outstanding | 1.79 Billion | 1.82 Billion | 1.84 Billion | 1.85 Billion | 1.87 Billion | 1.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.79 Billion | 1.82 Billion | 1.85 Billion | 1.85 Billion | 1.87 Billion | 1.93 Billion |
| Gross Margin | 0.76 | 0.81 | 0.80 | 0.80 | 0.79 | 0.78 |
| EBIT Margin | 0.12 | 0.16 | 0.17 | 0.18 | 0.24 | 0.24 |
| Profit Margin | 0.01 | 0.07 | 0.10 | 0.10 | 0.15 | 0.17 |
| EBITDA | 195.34 Billion | 240.45 Billion | 241.03 Billion | 219.83 Billion | 316.41 Billion | 313.72 Billion |
| Earnings Before Tax Margin | 0.08 | 0.09 | 0.12 | 0.11 | 0.19 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 462.49 Billion | 473.12 Billion | 1603.67 Billion | 414.6 Billion | 421.93 Billion | 392.14 Billion |
| Cost of Revenue | 116.92 Billion | 91.13 Billion | 391.3 Billion | 105.87 Billion | 75.89 Billion | 74.41 Billion |
| Gross Profit | 345.56 Billion | 381.98 Billion | 1212.36 Billion | 308.72 Billion | 346.03 Billion | 317.73 Billion |
| Operating Expenses | 285.04 Billion | 331.33 Billion | 1034.29 Billion | 271 Billion | 327.16 Billion | 320.95 Billion |
| Selling, General and Administrative Expenses | 199.53 Billion | 206.87 Billion | - | 193.14 Billion | 199.49 Billion | 179.28 Billion |
| Research and Development Expenses | 85.5 Billion | 86.82 Billion | - | 77.85 Billion | 74.38 Billion | 77.35 Billion |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 401.97 Billion | 422.46 Billion | 1425.6 Billion | 376.87 Billion | 403.06 Billion | 395.36 Billion |
| Operating Income | 60.52 Billion | 53.31 Billion | 178.07 Billion | 37.72 Billion | 18.96 Billion | 5.22 Billion |
| Interest Expense | 5.04 Billion | 4.49 Billion | 12 Billion | 4.18 Billion | 2.83 Billion | 2.26 Billion |
| Income Tax Expense | 2.63 Billion | 12.89 Billion | 7.92 Billion | -15.38 Billion | 2.8 Billion | 6.78 Billion |
| Earnings before Tax | 39.02 Billion | 50.49 Billion | 28.13 Billion | -45.95 Billion | 17.31 Billion | 5.32 Billion |
| Net Income | 35.9 Billion | 37.6 Billion | 17.04 Billion | -33.27 Billion | 14.51 Billion | -1.45 Billion |
| Earnings Per Share Basic | -0.81 | 21.00 | - | -18.39 | 8.09 | -0.81 |
| Earnings Per Share Diluted | -0.81 | 20.94 | - | -18.21 | 8.06 | -0.81 |
| Weighted Average Shares Outstanding | 1.8 Billion | 1.79 Billion | 1.79 Billion | 1.8 Billion | 1.79 Billion | 1.79 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.8 Billion | 1.79 Billion | 1.79 Billion | 1.82 Billion | 1.8 Billion | 1.79 Billion |
| Gross Margin | 0.75 | 0.81 | 0.76 | 0.74 | 0.82 | 0.81 |
| EBIT Margin | 0.20 | 0.22 | - | 0.21 | 0.16 | 0.09 |
| Profit Margin | 0.08 | 0.08 | 0.01 | -0.08 | 0.03 | -0.00 |
| EBITDA | 94.09 Billion | 103.58 Billion | - | 86.36 Billion | 66.8 Billion | 37.2 Billion |
| Earnings Before Tax Margin | 0.13 | 0.11 | 0.11 | 0.09 | 0.04 | 0.01 |
VSL
QTX
DREDGECORP
DWL
000972
MANYAVAR